Cited 33 times in
Phase II study of trastuzumab in combination with S-1 and cisplatin in the first-line treatment of human epidermal growth factor receptor HER2-positive advanced gastric cancer
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.